Yiling Pharm Realized ￥3,800 Million of Annual Revenue in 2016
date：2017-01-26
browse：（759）
Keyword：
Yiling Pharmaceutical (002603) published its annual report of 2016. In 2016, the company realized an operating revenue of ￥3,820 million with a year-on-year growth of 19.95%; and its net profit saw a year-on-year growth of 25.91%, realizing ￥542 million.
The company showed that, it has developed a series of healthcare food and nutritious health food aiming at the medicinal and edible plant nutrition area, children nutrition area and sub-health area, providing the rich product reserve for the company’s sustainable development in the future.
The latest article
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
